Sinotherapeutics
Manufacturing · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
ChinaPhone Number
+86 2168819009Website
www.sinotherapeutics.comRevenue
<$5 MillionIndustry
About Sinotherapeutics
Sinotherapeutics Org Chart
Is Sinotherapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Sinotherapeutics is spiking on competitors!
Earning: See what the market has to say on Sinotherapeutics recently announced quarterly report
Sinotherapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Sinotherapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if Sinotherapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Sinotherapeutics
Click to see if Sinotherapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Sinotherapeutics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Sinotherapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sinotherapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sinotherapeutics.
Sinotherapeutics Tech Stack
A closer look at the technologies used by Sinotherapeutics
Sinotherapeutics News & Media
Vitruvias Therapeutics Inc. Launches Shanghai-Based Sinotherapeutics’s Approved Version of Propafenone ER in the U.S.
AUBURN, Ala. & SHANGHAI--(BUSINESS WIRE)--Vitruvias Therapeutics Inc., an Auburn, Alabama-based finished-dose generic drug company, and Sinotherapeutics Inc., a Shanghai-based generic drug company, announced they have launched a bioequivalent FDA-approved version of Rythmol SR. Rythmol SR, known generically as propafenone hydrochloride, is an antiarrhythmic drug supplied in extended-release capsules of 225, 325 and 425 mg for oral administration. It is indicated for the treatment of sustaine
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Sinotherapeutics
Sinotherapeutics Inc. is a specialty pharmaceutical company focused on developing generic products that are of high commercial value and possess high technological barriers. Founded in 2012, the company is integrated with R&D, regulatory affairs for product registration (FDA and NMPA), clinical supply and commercial manufacturing, and sales and mar... Read More